These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26879281)

  • 1. Neurologic Outcomes in HIV-Exposed/Uninfected Infants Exposed to Antiretroviral Drugs During Pregnancy in Latin America and the Caribbean.
    Spaulding AB; Yu Q; Civitello L; Mussi-Pinhata MM; Pinto J; Gomes IM; Alarcón JO; Siberry GK; Harris DR; Hazra R
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):349-56. PubMed ID: 26879281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
    Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
    AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
    Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
    BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.
    Mussi-Pinhata MM; Freimanis L; Yamamoto AY; Korelitz J; Pinto JA; Cruz ML; Losso MH; Read JS;
    Pediatrics; 2007 Mar; 119(3):e694-704. PubMed ID: 17296782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte Telomere Length at Birth and During the Early Life of Children Exposed to but Uninfected With HIV After In Utero Exposure to Antiretrovirals.
    Ajaykumar A; Soudeyns H; Kakkar F; Brophy J; Bitnun A; Alimenti A; Albert AYK; Money DM; Côté HCF; ;
    J Infect Dis; 2018 Feb; 217(5):710-720. PubMed ID: 29228317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
    Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
    Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income Country.
    Goetghebuer T; Smolen KK; Adler C; Das J; McBride T; Smits G; Lecomte S; Haelterman E; Barlow P; Piedra PA; van der Klis F; Kollmann TR; Lauffenburger DA; Alter G; Levy J; Marchant A
    Clin Infect Dis; 2019 Mar; 68(7):1193-1203. PubMed ID: 30215689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester exposure to antiretroviral therapy and risk of birth defects.
    Phiri K; Hernandez-Diaz S; Dugan KB; Williams PL; Dudley JA; Jules A; Callahan ST; Seage GR; Cooper WO
    Pediatr Infect Dis J; 2014 Jul; 33(7):741-6. PubMed ID: 24445829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.
    Jao J; Kirmse B; Yu C; Qiu Y; Powis K; Nshom E; Epie F; Tih PM; Sperling RS; Abrams EJ; Geffner ME; LeRoith D; Kurland IJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3260-9. PubMed ID: 26133363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.
    Kirmse B; Yao TJ; Hofherr S; Kacanek D; Williams PL; Hobbs CV; Hazra R; Borkowsky W; Van Dyke RB; Summar M
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):339-48. PubMed ID: 26548585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.
    Guerra V; Leister EC; Williams PL; Starc TJ; Lipshultz SE; Wilkinson JD; Van Dyke RB; Hazra R; Colan SD
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):621-7. PubMed ID: 26794032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reactions associated with antiretroviral therapy during pregnancy.
    Santini-Oliveira M; Grinsztejn B
    Expert Opin Drug Saf; 2014 Dec; 13(12):1623-52. PubMed ID: 25390463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
    AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
    Ejigu Y; Magnus JH; Sundby J; Magnus MC
    Pediatr Infect Dis J; 2020 Aug; 39(8):730-736. PubMed ID: 32516280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.
    Rice ML; Zeldow B; Siberry GK; Purswani M; Malee K; Hoffman HJ; Frederick T; Buchanan A; Sirois PA; Allison SM; Williams PL;
    Pediatr Infect Dis J; 2013 Oct; 32(10):e406-13. PubMed ID: 24067563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
    Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
    AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.
    Sirois PA; Huo Y; Williams PL; Malee K; Garvie PA; Kammerer B; Rich K; Van Dyke RB; Nozyce ML;
    Pediatr Infect Dis J; 2013 Jun; 32(6):648-55. PubMed ID: 23340561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.